(Total Views: 528)
Posted On: 08/27/2021 4:26:17 PM
Post# of 153907
On November 19, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for emergency use of baricitinib (Olumiant). If this stuff worked, thousands of lives would have been saved, so it's quite obvious it doesn't work.
Makes one really pissed with the FDA given the results for the first 14 days on Leronlimab.
Why doesn't the FDA issue an EUA for Leronlimab for critical patients but only for the first 14 days? Then they can go on Remdesivir and get sick again.
Makes one really pissed with the FDA given the results for the first 14 days on Leronlimab.
Why doesn't the FDA issue an EUA for Leronlimab for critical patients but only for the first 14 days? Then they can go on Remdesivir and get sick again.
(0)
(0)
